KAKEN PHARMACEUTICAL

kaken-pharmaceutical-logo

Kaken Pharmaceutical is a specialty pharmaceutical company that develops and commercializes novel pharmaceuticals and medical devices.

#SimilarOrganizations #People #Financial #More

KAKEN PHARMACEUTICAL

Social Links:

Industry:
Health Care Manufacturing Medical Device Pharmaceutical

Founded:
1948-03-01

Status:
Active

Contact:
81-3-5977-5002

Technology used in webpage:
Apple Mobile Web Clips Icon Apache Apache 2.4 OpenSSL GlobalSign GlobalSign Domain Verification Red Hat Enterprise Linux Internap


Similar Organizations

jaber-ibn-hayyan-pharmaceutical-logo

Jaber Ibn Hayyan Pharmaceutical

Jaber Ibn Hayyan Pharmaceutical manufactures drugs like anti-biotic, non-antibiotic , topical, oral and others.

kilitch-drugs-logo

Kilitch Drugs

Kilitch Drugs is a Pharma Company that provides like Parenteral solutions, Effervescent, Nutritional Products & Medical devices.

merck-logo

Merck

Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.

synmosa-biopharma-logo

Synmosa Biopharma

Synmosa is a specialty pharmaceutical corporation that engages in diversified development that includes acting as an agent, manufacturing.

well-pharmaceutical-logo

Well Pharmaceutical

Well Pharmaceutical is a supplier of pharmaceutical excipients and high-end lubricant base oils and special surfactants.

zhejiang-jingxin-pharmaceutical-logo

Zhejiang Jingxin Pharmaceutical

Zhejiang Jingxin Pharmaceutical is a listed pharmaceutical company integrating R&D, production and sales.

Current Employees Featured

not_available_image

Hiroyuki Horiuchi
Hiroyuki Horiuchi CEO, President and Director @ Kaken Pharmaceutical
CEO, President and Director
2020-01-01

Stock Details


Company's stock symbol is TYO:4521

Acquisitions List

Date Company Article Price
2021-11-30 ARTham Therapeutics ARTham Therapeutics acquired by Kaken Pharmaceutical 5.5 B JPY

Investments List

Date Company Article Money raised
2021-01-29 GENEX Kaken Pharmaceutical investment in Seed Round - GENEX N/A

More informations about "Kaken Pharmaceutical"

Management Team | KAKEN PHARMACEUTICAL CO., LTD.

Director, Pharmaceutical Common Achievement Tests Organization (to present) Oct. 2018: Board Member, Japan Society for Pharmaceutical Education (to present) Apr. 2023: Professor, Education Research Center for Pharmaceutical โ€ฆSee details»

Kaken Pharmaceutical - Crunchbase Investor Profile

Kaken Pharmaceutical produces and supplies agrochemicals, feed additives, and veterinary drugs. They also offer pesticides such as horticultural fungicide, lawn fungicide, acaricide, box application agents for paddy rice, temacat flowable, โ€ฆSee details»

Kaken Pharmaceutical Co., Ltd. (4521.T) - Yahoo Finance

Kaken Pharmaceutical Co., Ltd. was founded in 1917 and is headquartered in Tokyo, Japan. Corporate Governance Kaken Pharmaceutical Co., Ltd.โ€™s ISS Governance QualityScore as of โ€ฆSee details»

Kaken Pharmaceutical Company Description - Stock Analysis

Nov 1, 2024 The company offers pharmaceutical products and medical devices, such as Clenafin, a topical treatment for onychomycosis; Artz, an anti-osteoarthritis agent; Fiblast, a โ€ฆSee details»

KAKEN Pharmaceutical Co., Ltd. - eu-japan.eu

2 BUSINESS DEVELOPMENT Medical Device 10.9% Agro-veterinary 5.5% Pharmaceuticals 78.8% Others 4.8% Head Office๏ผšTokyo, Japan Founded: March 1, 1948 Employees: 1,397 โ€ฆSee details»

Kaken Pharmaceutical - Funding, Financials, Valuation & Investors

Kaken Pharmaceutical manufactures and sells pharmaceuticals and medical equipment.See details»

About KAKEN | KAKEN PHARMACEUTICAL CO., LTD.

About KAKEN of Kaken Pharmaceutical Co.,Ltd.See details»

Kaken Pharmaceutical Co., Ltd. - Drug pipelines, Patents ... - Patsnap

Marketing approval for SI-6603 in Japan was obtained from the Japanese Ministry of Health, Labour and Welfare in March 2018 and SI-6603 has been marketed in Japan only as โ€ฆSee details»

KAKEN at a Glance | KAKEN PHARMACEUTICAL CO., LTD.

Kaken Pharmaceutical (KAKEN) is an R&D-driven pharmaceutical company that was established after the reorganization of the Institute of Physical and Chemical Research (Riken) in 1948. To return smiles to patients and their families, โ€ฆSee details»

Numab Therapeutics and Kaken Pharmaceutical Form Co โ€ฆ

About Kaken Pharmaceutical Kaken Pharmaceutical Co., Ltd. (KAKEN) is a specialty pharmaceutical company in Japan with strong experience in developing and commercializing โ€ฆSee details»

Kaken Pharmaceutical Co Ltd, 4521:TYO summary - FT.com

Nov 21, 2024 KAKEN PHARMACEUTICAL CO., LTD. is a Japan-based company engaged in the production and sale of pharmaceutical products. The Company operates in two business โ€ฆSee details»

Kaken Pharmaceutical Co., Ltd. (4521.T) - Yahoo Finance

Find the latest Kaken Pharmaceutical Co., Ltd. (4521.T) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»

Kaken Pharmaceutical - Craft

Oct 11, 2024 Kaken Pharmaceutical is a company focusing on the development and commercialization of pharmaceuticals and medical devices in the orthopedics and โ€ฆSee details»

Kaken Pharmaceutical sees highest patent filings and grants โ€ฆ

Jul 21, 2024 Kaken Pharmaceutical has been focused on protecting inventions in Canada(CA) with one publication in Q2 2024 The Canada(CA) Patent Office dominates the patent grants โ€ฆSee details»

Kaken Pharmaceutical : License and Co-Development Agreement โ€ฆ

Tokyo, Jan 13, 2021 - Kaken Pharmaceutical Co., Ltd. ('Kaken', head office Bunkyo-ku, Tokyo; President and Representative Director Hiroyuki Horiuchi) announced the signing on January โ€ฆSee details»

ARTham Therapeutics acquired by Kaken Pharmaceutical

Nov 30, 2021 Kaken Pharmaceutical acquires ARTham Therapeutics on 2021-11-30 for $48542261. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. โ€ฆSee details»

Trafermin - Drug Targets, Indications, Patents - Synapse - Patsnap

Nov 21, 2024 Rapid and scar-free healing of burn wounds is an urgent clinical issue. Basic fibroblast growth factor (bFGF) has been proven to promote the healing of burn wounds by โ€ฆSee details»

Development Pipeline | KAKEN PHARMACEUTICAL CO., LTD.

May 14, 2024 Development Pipeline of Kaken Pharmaceutical Co.,Ltd. Development Code Planned Indication Development Stage Notes; KAR: Head lice: Phase โ…ขSee details»

Investor Relations | KAKEN PHARMACEUTICAL CO., LTD.

Explore the investor relations of Kaken Pharmaceutical Co., Ltd, a company with a strong focus on pharmaceutical innovation.See details»

linkstock.net © 2022. All rights reserved